Multidistrict litigation is “littered with examples of undisclosed non-party involvement gone wrong,” according to Sanofi-Aventis U.S. LLC in a motion renewing its demand that plaintiffs attorneys disclose outside funding of lawsuits filed over breast cancer drug Taxotere.
Among the ills Sanofi lawyers depicted: fee arrangements with doctors, medical screenings of plaintiffs, and outside funders that allowed doctors to charge inflated costs on medical liens.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
